Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

112

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Immunotherapy for glioblastoma and its microenvironment

Related Posts

Shaping the synapse through neuronal activity-regulated miRNAs

Shaping the synapse through neuronal activity-regulated...

75

The enigma of maladaptation in gastric pathophysiology

The enigma of maladaptation in gastric pathophysiology

75

WUSCHEL-D1 upregulation enhances grain number by inducing formation of multiovary-producing florets in wheat

WUSCHEL-D1 upregulation enhances grain number by induci...

23